2m 2m 2m 2m 2m 2m 2m
CRTV MDCL HLD (CELZ)
NASDAQ
$1.97+$0.04 (+2.12%)
Price as of Jun 23, 2026 5:13 PM EDT- $7.1MMarket Cap
- -21.06%1-Year Change
- BiotechnologyIndustry
CRTV MDCL HLD (CELZ)
$1.97+$0.04 (+2.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6,000 -45.45% | 11,000 +22.22% | 9,000 -89.84% | 88,600 +0.96% | |
Cost of Revenue | 2,194 -50.14% | 4,400 +22.22% | 3,600 -87.36% | 28,491 -40.58% | |
Gross Profit | 3,806 -42.33% | 6,600 +22.22% | 5,400 -91.02% | 60,109 +51.01% | |
Sales and Marketing Expense | 3.8M +16.18% | 3.2M -9.02% | 3.6M -9.72% | 3.9M +33.03% | |
Research and Development Expense | -2.3M -5.87% | -2.4M +21.83% | -2.0M -68.56% | -6.3M +5,641.76% | |
Depreciation and Amortization Expense | 123,327 +11.66% | 110,452 +16.78% | 94,584 +2.71% | 92,084 0.00% | |
Total Operating Expenses | 6.1M +6.89% | 5.8M +2.22% | 5.6M -45.41% | 10.3M +225.50% | |
Operating Profit | -6.1M +6.95% | -5.7M +2.20% | -5.6M -45.14% | -10.2M +227.72% | |
Interest Income | 147,806 -40.97% | 250,380 -24.94% | 333,558 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 147,806 -40.97% | 250,380 -24.94% | 333,558 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 147,806 -40.97% | 250,380 -24.94% | 333,558 +232.47% | 100,328 -99.55% | |
Income before Taxes | -6.0M +9.13% | -5.5M +3.91% | -5.3M -47.88% | -10.1M -152.80% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -6.0M +9.13% | -5.5M +3.91% | -5.3M -47.88% | -10.1M -152.80% | |
Net Income from Continuing Operations Applicable to Common | -6.0M +9.13% | -5.5M +3.91% | -5.3M -47.88% | -10.1M -152.80% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | -0.93 -112.62% | |
Diluted EPS and Net Income | -2.52 -32.08% | -3.71 N/A | N/A N/A | -0.93 -116.58% | |
Basic Weighted Average Shares | 2.4M +60.95% | 1.5M N/A | N/A N/A | 10.9M +319.65% | |
Diluted Weighted Average Shares | 2.4M +60.95% | 1.5M N/A | N/A N/A | 10.9M +319.65% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.2M +21.34% | 5.9M +71.35% | 3.5M -58.33% | 8.3M -22.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.2M +21.34% | 5.9M +71.35% | 3.5M -58.33% | 8.3M -22.41% | |
Total Current Assets | 7.4M +20.60% | 6.1M -40.27% | 10.3M -45.21% | 18.7M +74.60% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 3,281 0.00% | 3,281 0.00% | 3,281 0.00% | 3,281 0.00% | |
Total Assets | 7.8M +17.10% | 6.7M -37.76% | 10.7M -44.15% | 19.2M +70.27% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 14,194 0.00% | |
Total Current Liabilities | 284,880 -13.05% | 327,644 -11.78% | 371,394 -88.82% | 3.3M +216.21% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 498,800 0.00% | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Liabilities | 284,880 -13.05% | 327,644 -11.78% | 371,394 -88.82% | 3.3M +216.21% | |
Retained Earnings | -70.6M +9.28% | -64.6M +9.30% | -59.1M +9.82% | -53.8M +23.23% | |
Total Stockholders Equity | 7.5M +18.50% | 6.3M -38.69% | 10.3M -34.80% | 15.9M +55.27% | |
Total Shares Outstanding | 3.7M +111.43% | 1.7M +27.29% | 1.4M -90.24% | 14.1M +122.06% | |
Cash Flow | |||||
Cash from Operating Activities | -5.9M +10.47% | -5.3M -33.96% | -8.0M +2.96% | -7.8M +251.88% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -50,500 -100.80% | 6.3M +83.45% | 3.4M +134.18% | -10.1M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.2M +393.23% | 1.5M +636.86% | -270,952 -101.75% | 15.5M +20.48% | |
Financials Ratio | |||||
Gross Margin | 63.43% +5.72% | 60.00% 0.00% | 60.00% -11.56% | 67.84% +49.57% | |
Operating Margin | -102,380.23% +96.07% | -52,216.92% -16.38% | -62,445.91% +440.07% | -11,562.50% +224.59% | |
Return on Assets | -82.81% +31.03% | -63.20% +78.73% | -35.36% -46.92% | -66.62% -120.78% | |
Return on Equity | -86.53% +31.41% | -65.85% +63.22% | -40.34% -48.14% | -77.78% -40.11% | |
Revenue Growth | -45.45% -304.55% | 22.22% +124.73% | -89.84% -9,418.74% | 0.96% +102.07% | |
Current Ratio | 25.97 +38.70% | 18.73 -32.29% | 27.66 +389.99% | 5.64 -44.78% | |
Cash Ratio | 25.30 +39.56% | 18.13 +94.23% | 9.33 +272.66% | 2.50 -75.46% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.03 -35.66% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.03 -41.32% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow